A
ApnimedClinical-stage biotech developing Oxnimbi (AD109), the first investigational oral pill for obstructive sleep apnea.
3 Pulse stories
TM
Tenon MedicalTenon Medical develops the Catamaran, a minimally invasive titanium implant system for sacroiliac joint fusion to treat lower back pain.
1 Pulse story
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2017
Founded
2012
Cambridge, Massachusetts
HQ
Los Gatos, California
Public (APMD)
Status
Public (TNON)
Apnimed investors
ShionogiColumbia Seligman Technology and Information FundAlpha Wave GlobalMorningside VenturesColumbia ManagementNexPoint Asset ManagementSectoral Asset Management
Tenon Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Apnimed and Tenon Medical.